These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 8894600

  • 1. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vivo.
    Taniguchi H, Yazaki N, Yomota E, Shikano T, Endo T, Nagasaki M.
    Eur J Pharmacol; 1996 Sep 26; 312(2):227-33. PubMed ID: 8894600
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vitro.
    Taniguchi H, Yazaki N, Endo T, Nagasaki M.
    Eur J Pharmacol; 1996 May 23; 304(1-3):147-54. PubMed ID: 8813597
    [Abstract] [Full Text] [Related]

  • 3. Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
    Taniguchi H, Yomota E, Kume E, Shikano T, Endo T, Nagasaki M.
    Jpn J Pharmacol; 1997 Feb 23; 73(2):105-12. PubMed ID: 9074944
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological profile of FK480, a novel cholecystokinin type-A receptor antagonist: comparison to loxiglumide.
    Ito H, Sogabe H, Nakarai T, Sato Y, Tomoi M, Kadowaki M, Matsuo M, Tokoro K, Yoshida K.
    J Pharmacol Exp Ther; 1994 Feb 23; 268(2):571-5. PubMed ID: 7509389
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the effects of two cholecystokinin-receptor antagonists, loxiglumide and L-364,718, on the pancreatic secretory response to intraduodenal tryptophan in dogs.
    Niebergall-Roth E, Teyssen S, Wetzel D, Hartel M, Beglinger C, Riepl RL, Singer MV.
    Scand J Gastroenterol; 1996 Jul 23; 31(7):723-32. PubMed ID: 8819225
    [Abstract] [Full Text] [Related]

  • 6. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
    Otsuki M, Fujii M, Nakamura T, Okabayashi Y, Tani S, Fujisawa T, Koide M, Baba S.
    Dig Dis Sci; 1989 Jun 23; 34(6):857-64. PubMed ID: 2470557
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological profile of TP-680, a new cholecystokininA receptor antagonist.
    Akiyama T, Tachibana I, Hirohata Y, Shirohara H, Yamamoto M, Otsuki M.
    Br J Pharmacol; 1996 Apr 23; 117(7):1558-64. PubMed ID: 8730754
    [Abstract] [Full Text] [Related]

  • 8. Characterization of a new cholecystokinin receptor antagonist FK480 in in vitro isolated rat pancreatic acini.
    Akiyama T, Otsuki M.
    Pancreas; 1994 May 23; 9(3):324-31. PubMed ID: 8022754
    [Abstract] [Full Text] [Related]

  • 9. Pharmacologic profile of TS-941, a new benzodiazepine derivative cholecystokinin-receptor antagonist, in in vitro isolated rat pancreatic acini.
    Tashiro M, Hirohata Y, Kihara Y, Akiyama T, Otsuki M.
    Pancreas; 1999 Mar 23; 18(2):156-64. PubMed ID: 10090413
    [Abstract] [Full Text] [Related]

  • 10. Combined dose-ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea-pig gall bladder.
    Bishop LA, Gerskowitch VP, Hull RA, Shankley NP, Black JW.
    Br J Pharmacol; 1992 May 23; 106(1):61-6. PubMed ID: 1504732
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of a novel cholecystokinin receptor antagonist, FK480, administered intraduodenally, on pancreatic secretion in rats.
    Moriyoshi Y, Shiratori K, Takeuchi T, Watanabe S.
    Pancreas; 1995 Apr 23; 10(3):295-300. PubMed ID: 7542771
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
    Louie DS, Liang JP, Owyang C.
    Am J Physiol; 1988 Sep 23; 255(3 Pt 1):G261-6. PubMed ID: 2458681
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Biochemical and pharmacological profiles of loxiglumide, a novel cholecystokinin-A receptor antagonist.
    Fukamizu Y, Nakajima T, Kimura K, Kanda H, Fujii M, Saito T, Kasai H.
    Arzneimittelforschung; 1998 Jan 23; 48(1):58-64. PubMed ID: 9522034
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anticholecystokinin activities of loxiglumide.
    Setnikar I, Bani M, Cereda R, Chisté R, Makovec F, Pacini MA, Revel L.
    Arzneimittelforschung; 1987 Oct 23; 37(10):1168-71. PubMed ID: 3435589
    [Abstract] [Full Text] [Related]

  • 20. Inhibitory effect of intraduodenal infusion of loxiglumide on pancreatic exocrine secretion.
    Tanikawa M, Hayakawa T, Kondo T, Shibata T, Kitagawa M, Kodaira T, Hamaoka T.
    Arzneimittelforschung; 1993 Jan 23; 43(1):35-9. PubMed ID: 8447844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.